🔍
Search Results - michael+leff
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Engineered Cytokine-antibody Fusion for Targeted Expansion of Immune Effector Cells
Unmet NeedGlobal revenue from the cytokine therapeutics market was valued at approximately $16.5 billion in 2018, and cytokine immunotherapy is a promising field of anti-cancer treatments for a broad range of cancer types. In particular, interleukin-2 (IL-2) therapy is shown to stimulate anti-cancer immunity. However, IL-2 activates contradictory immune...
Published: 3/14/2025
|
Inventor(s):
Jamie Spangler
,
Jakub Tomala
,
Michael Leff
,
Seth Ludwig
,
Elissa Leonard
,
Marek Kovar
,
Jirina Kovarova
Keywords(s):
Biologics
,
Cancers
,
Disease Indication
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
Category(s):
Technology Classifications > Therapeutic Modalities > Antibodies
,
Clinical and Disease Specializations > Oncology
,
Technology Classifications > Therapeutic Modalities > Immunotherapies
,
Technology Classifications > Therapeutic Modalities > Biologics
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum